Freshfields Advises Materialise NV on Successful Euronext Brussels Listing

"Freshfields advised Materialise NV on the admission to trading of its ordinary shares on Euronext Brussels on 20 November 2025, with KBC Securities acting as listing agent. The admission creates a dual‑listing alongside Materialise’s Nasdaq ADSs. Materialise is a Belgium‑headquartered leader in 3D‑printed medical devices and additive manufacturing software and services."

Freshfields advised Materialise NV on its admission to trading on Euronext Brussels; KBC Securities acted as listing agent for Materialise. The transaction comprised the listing of Materialise NV’s ordinary shares on Euronext Brussels effective 20 November 2025. Prior to the Brussels admission, Materialise’s ordinary shares were publicly traded on Nasdaq through American Depositary Shares (ADSs) representing those ordinary shares. With the admission to trading on Euronext Brussels, Materialise now maintains a dual‑listing structure. Materialise NV is a global leader in 3D‑printed medical devices and software and a pioneer in additive manufacturing software and services. Headquartered in Belgium with branches worldwide, the company combines a large team of software developers with one of the world’s most comprehensive 3D printing facilities. Freshfields advised on key aspects of the transaction, including the drafting of the prospectus, coordination of the listing process, and governance and post‑listing compliance matters. Freshfields represented client(s) Materialise NV with a team composed by: partner Deborah Janssens, counsel Sigrid Ververken, and associates Riet Devriendt and Emma Heijmans; counsel Nikolaas Van Robbroeck and associate Bo Debreuck, who advised on tax aspects.

Freshfields Advises Materialise NV on Successful Euronext Brussels Listing

Read the full story

Cookie Preferences

Strictly Necessary

Analytics & Statistics

Marketing & Ads